EI
TGAN

Ellevest Inc’s Transphorm, Inc. Common Stock TGAN Stock Holding History

Ellevest Inc’s Portfolio TGAN Stock Details TGAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-179
Closed -$714 – 1756
2023
Q1 		$714 Buy
+179
New +$788 ﹤0.01% 1632

Other funds holding TGAN

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ellevest Inc's TGAN Position: Q2 2023 in Review

Ellevest Inc sold out of Transphorm, Inc. Common Stock (TGAN) in Q2 2023, closing a stake of 179 shares — an estimated $714 sold.

Ellevest Inc first reported a position in TGAN in Q1 2023 and held it in 1 quarter. The position peaked at $714 in Q1 2023. 41 funds tracked by Wall St. Rank hold TGAN as of Q2 2023.

  • Ellevest Inc reported no remaining Transphorm, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Ellevest Inc sold 179 Transphorm, Inc. Common Stock shares in Q2 2023, an estimated $714.
  • Ellevest Inc first reported a position in Transphorm, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
  • Ellevest Inc's Transphorm, Inc. Common Stock position peaked at $714 in Q1 2023.
  • 41 funds tracked by Wall St. Rank held Transphorm, Inc. Common Stock as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.